Beyond Meat(US:BYND) Benzinga·2025-11-14 14:54Core Insights - U.S. stocks experienced a decline, with the Dow Jones index dropping over 500 points on Friday [1] - Legence Corp reported mixed third-quarter results in its first earnings report since going public, leading to a significant increase in its share price [1] Company Performance - Legence Corp posted revenue of $708.01 million, representing a 26.2% year-over-year increase and surpassing analyst expectations of $639.78 million [2] - The company's gross margin decreased to 20.9% from 21.1% a year earlier, while earnings fell short of forecasts, with an EPS loss of 2 cents compared to consensus estimates of a profit of 6 cents [2] - Following the earnings report, Legence shares surged by 10.7% to $36.89 [2] Other Notable Stock Movements - Cidara Therapeutics Inc shares rose 105.6% to $217.87 after Merck agreed to acquire the company for $221.50 per share in a $9.2 billion cash deal [4] - Invivyd Inc gained 26.5% to $2.24 after reporting better-than-expected quarterly financial results [4] - Scholar Rock Holding Corp surged 22.8% to $36.91 following a $200 million equity offering [4] - Avadel Pharmaceuticals PLC increased by 20.1% to $23.12 after receiving an unsolicited proposal from Lundbeck [4] - Ondas Holdings Inc rose 13% to $7.42 after reporting better-than-expected third-quarter results and raising its FY25 sales guidance [4] - Omeros Corp gained 11.9% to $7.03 following a narrower-than-expected quarterly loss [4] - Figure Technology Solutions Inc shares jumped 10.6% to $38.26 after positive quarterly results [4] - Beyond Meat Inc shares increased by 9.2% to $1.10 after announcing the determination of the conversion rate for its convertible notes due 2030 [4] - RLX Technology Inc shares rose 8.8% to $2.54 following third-quarter results [4] - PomDoctor Ltd gained 7.7% to $3.86 [4] - Cytek Biosciences Inc shares increased by 7.2% to $4.90 [4]